114 related articles for article (PubMed ID: 10580376)
1. The profile of FR140423, a novel anti-inflammatory compound, in yeast-induced rat hyperalgesia.
Ochi T; Fujii T; Motoyama Y; Goto T
Jpn J Pharmacol; 1999 Sep; 81(1):94-8. PubMed ID: 10580376
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory and analgesic effects of a novel pyrazole derivative, FR140423.
Ochi T; Jobo-Magari K; Yonezawa A; Matsumori K; Fujii T
Eur J Pharmacol; 1999 Jan; 365(2-3):259-66. PubMed ID: 9988110
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory activity of a novel selective cyclooxygenase-2 inhibitor, FR140423, on type II collagen-induced arthritis in Lewis rats.
Ochi T; Goto T
Prostaglandins Other Lipid Mediat; 2001 Dec; 66(4):317-27. PubMed ID: 11785783
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory effect of FR140423, a novel selective cyclo-oxygenase-2 inhibitor, in rat adjuvant arthritis without gastrointestinal side effects.
Ochi T; Goto T
J Pharm Pharmacol; 2000 May; 52(5):553-60. PubMed ID: 10864144
[TBL] [Abstract][Full Text] [Related]
5. Effect of systemic FR140423, a new analgesic compound, in a rat model of postoperative pain: contribution of delta-opioid receptors.
Ochi T; Ohkubo Y; Mutoh S
Neurosci Lett; 2003 Oct; 350(1):29-32. PubMed ID: 12962910
[TBL] [Abstract][Full Text] [Related]
6. Antinociceptive properties of FR140423 mediated through spinal delta-, but not mu- and kappa-, opioid receptors.
Ochi T; Fujii T; Motoyama Y; Goto T
Eur J Pharmacol; 1999 Sep; 380(2-3):73-9. PubMed ID: 10513565
[TBL] [Abstract][Full Text] [Related]
7. The spinal antinociceptive effect of FR140423 is mediated through kyotorphin receptors.
Ochi T; Motoyama Y; Goto T
Life Sci; 2000; 66(23):2239-45. PubMed ID: 10855944
[TBL] [Abstract][Full Text] [Related]
8. The antinociceptive effect of FR140423 in mice: involvement of spinal alpha(2)-adrenoceptors.
Ochi T; Goto T
Eur J Pharmacol; 2000 Jul; 400(2-3):199-203. PubMed ID: 10988334
[TBL] [Abstract][Full Text] [Related]
9. Endogenous opioids mediate the hypoalgesia induced by selective inhibitors of cyclo-oxygenase 2 in rat paws treated with carrageenan.
França DS; Ferreira-Alves DL; Duarte ID; Ribeiro MC; Rezende RM; Bakhle YS; Francischi JN
Neuropharmacology; 2006 Jul; 51(1):37-43. PubMed ID: 16620880
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
11. The antinociceptive effect induced by FR140423 is mediated through spinal 5-HT2A and 5-HT3 receptors.
Ochi T; Goto T
Eur J Pharmacol; 2000 Dec; 409(2):167-72. PubMed ID: 11104830
[TBL] [Abstract][Full Text] [Related]
12. The novel inhibitor of the heterotrimeric G-protein complex, BIM-46187, elicits anti-hyperalgesic properties and synergizes with morphine.
Favre-Guilmard C; Zeroual-Hider H; Soulard C; Touvay C; Chabrier PE; Prevost G; Auguet M
Eur J Pharmacol; 2008 Oct; 594(1-3):70-6. PubMed ID: 18664366
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the antihyperalgesic action of a novel peripheral mu-opioid receptor agonist--loperamide.
Nozaki-Taguchi N; Yaksh TL
Anesthesiology; 1999 Jan; 90(1):225-34. PubMed ID: 9915332
[TBL] [Abstract][Full Text] [Related]
14. The mechanism of action of the new antiinflammatory compound ML3000: inhibition of 5-LOX and COX-1/2.
Tries S; Neupert W; Laufer S
Inflamm Res; 2002 Mar; 51(3):135-43. PubMed ID: 12005204
[TBL] [Abstract][Full Text] [Related]
15. The novel analgesic compound OT-7100 (5-n-butyl-7-(3,4,5-trimethoxybenzoylamino)pyrazolo[1,5-a]pyrimid ine) attenuates mechanical nociceptive responses in animal models of acute and peripheral neuropathic hyperalgesia.
Yasuda T; Iwamoto T; Ohara M; Sato S; Kohri H; Noguchi K; Senba E
Jpn J Pharmacol; 1999 Jan; 79(1):65-73. PubMed ID: 10082319
[TBL] [Abstract][Full Text] [Related]
16. Role of cyclooxygenase-2, but not cyclooxygenase-1, on type II collagen-induced arthritis in DBA/1J mice.
Ochi T; Ohkubo Y; Mutoh S
Biochem Pharmacol; 2003 Sep; 66(6):1055-60. PubMed ID: 12963493
[TBL] [Abstract][Full Text] [Related]
17. Effects of sevoflurane on carrageenan- and fentanyl-induced pain hypersensitivity in Sprague-Dawley rats.
Richebé P; Rivalan B; Rivat C; Laulin JP; Janvier G; Maurette P; Simonnet G
Can J Anaesth; 2009 Feb; 56(2):126-35. PubMed ID: 19247760
[TBL] [Abstract][Full Text] [Related]
18. III - Prostaglandin hyperalgesia: relevance of the peripheral effect for the analgesic action of opioid-antagonists.
Ferreira SH; Nakamura M
Prostaglandins; 1979 Aug; 18(2):201-8. PubMed ID: 523678
[TBL] [Abstract][Full Text] [Related]
19. Ketorolac prevents recurrent withdrawal induced hyperalgesia but does not inhibit tolerance to spinal morphine in the rat.
Dunbar SA; Karamian I; Zhang J
Eur J Pain; 2007 Jan; 11(1):1-6. PubMed ID: 16448827
[TBL] [Abstract][Full Text] [Related]
20. 3-Methyl-5-hydroxy-5-trichloromethyl-1H-1-pyrazolcarboxyamide induces antinociception.
de Souza FR; Fighera MR; Lima TT; de Bastiani J; Barcellos IB; Almeida CE; de Oliveira MR; Bonacorso HG; Flores AE; de Mello CF
Pharmacol Biochem Behav; 2001 Mar; 68(3):525-30. PubMed ID: 11325408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
